Aster DM Healthcare Ltd
Aster DM Healthcare Limited is one of the largest integrated private healthcare service providers operating in GCC (Gulf Cooperation Council) countries and an emerging player in India. With an inherent emphasis on clinical excellence, it is one of the few entities in the world with a strong presence across primary, secondary, tertiary and quaternary healthcare. [1]
- Market Cap ₹ 31,945 Cr.
- Current Price ₹ 617
- High / Low ₹ 732 / 386
- Stock P/E 94.6
- Book Value ₹ 85.6
- Dividend Yield 0.82 %
- ROCE 139 %
- ROE 200 %
- Face Value ₹ 10.0
Pros
- Company has delivered good profit growth of 149% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 73.5%
- Company has been maintaining a healthy dividend payout of 1,274%
- Company's median sales growth is 32.8% of last 10 years
Cons
- Stock is trading at 7.19 times its book value
- Promoters have pledged or encumbered 40.7% of their holding.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Hospital
Part of BSE 500 BSE Healthcare Nifty 500 BSE SmallCap Nifty Smallcap 100
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 53 | 189 | 380 | 530 | 595 | 760 | 747 | 1,116 | 1,534 | 2,036 | 2,320 | 2,445 | |
| 12 | 114 | 227 | 427 | 519 | 554 | 686 | 704 | 963 | 1,240 | 1,671 | 1,858 | 1,936 | |
| Operating Profit | -11 | -60 | -38 | -47 | 12 | 41 | 74 | 42 | 153 | 293 | 366 | 463 | 509 |
| OPM % | -1,256% | -114% | -20% | -12% | 2% | 7% | 10% | 6% | 14% | 19% | 18% | 20% | 21% |
| 86 | 40 | 51 | 390 | 14 | 83 | 113 | 21 | 82 | 50 | 48 | 6,061 | 101 | |
| Interest | 3 | 34 | 135 | 228 | 54 | 11 | 33 | 36 | 47 | 56 | 83 | 91 | 89 |
| Depreciation | 1 | 22 | 48 | 68 | 59 | 64 | 89 | 95 | 99 | 104 | 121 | 145 | 150 |
| Profit before tax | 72 | -77 | -170 | 47 | -87 | 49 | 65 | -68 | 90 | 182 | 209 | 6,288 | 371 |
| Tax % | 2% | 1% | 0% | 0% | 0% | 1% | 6% | 1% | -0% | 5% | 25% | 1% | |
| 70 | -78 | -170 | 47 | -87 | 48 | 61 | -69 | 90 | 173 | 157 | 6,209 | 296 | |
| EPS in Rs | 1.86 | -2.00 | -4.21 | 1.16 | -1.73 | 0.95 | 1.21 | -1.38 | 1.81 | 3.47 | 3.14 | 124.30 | 5.80 |
| Dividend Payout % | 89% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 3,819% | 4% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 46% |
| 5 Years: | 25% |
| 3 Years: | 28% |
| TTM: | 9% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 55% |
| 5 Years: | 149% |
| 3 Years: | 302% |
| TTM: | -94% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 30% |
| 3 Years: | 41% |
| 1 Year: | 29% |
| Return on Equity | |
|---|---|
| 10 Years: | 23% |
| 5 Years: | 44% |
| 3 Years: | 74% |
| Last Year: | 200% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 375 | 389 | 403 | 403 | 505 | 505 | 497 | 497 | 500 | 500 | 500 | 500 | 518 |
| Reserves | 103 | 209 | 535 | 1,925 | 2,421 | 2,475 | 2,434 | 2,367 | 2,081 | 2,257 | 2,420 | 2,466 | 3,917 |
| 266 | 384 | 1,914 | 645 | 110 | 125 | 349 | 417 | 895 | 1,072 | 1,216 | 1,574 | 1,231 | |
| 24 | 124 | 168 | 251 | 257 | 271 | 273 | 307 | 286 | 274 | 402 | 425 | 456 | |
| Total Liabilities | 768 | 1,105 | 3,021 | 3,224 | 3,293 | 3,376 | 3,552 | 3,589 | 3,762 | 4,102 | 4,538 | 4,965 | 6,122 |
| 37 | 469 | 547 | 714 | 772 | 753 | 1,016 | 1,009 | 1,013 | 1,008 | 1,333 | 1,760 | 1,852 | |
| CWIP | 287 | 100 | 130 | 63 | 17 | 70 | 20 | 11 | 23 | 67 | 39 | 55 | 56 |
| Investments | 266 | 317 | 2,037 | 2,137 | 2,086 | 2,095 | 2,150 | 2,151 | 2,166 | 2,141 | 2,176 | 1,009 | 2,127 |
| 178 | 219 | 307 | 309 | 417 | 458 | 366 | 418 | 560 | 886 | 990 | 2,140 | 2,088 | |
| Total Assets | 768 | 1,105 | 3,021 | 3,224 | 3,293 | 3,376 | 3,552 | 3,589 | 3,762 | 4,102 | 4,538 | 4,965 | 6,122 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -51 | -3 | -51 | 98 | 42 | 78 | 246 | 413 | 367 | ||||
| -251 | -18 | -36 | 40 | -38 | -49 | -332 | -342 | 6,023 | ||||
| 222 | 95 | 7 | -126 | -12 | -18 | 92 | -67 | -6,298 | ||||
| Net Cash Flow | -80 | 74 | -80 | 12 | -9 | 11 | 6 | 3 | 92 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 742 | 41 | 28 | 24 | 21 | 22 | 21 | 21 | 20 | 26 | 23 | 22 |
| Inventory Days | 171 | 100 | 66 | 42 | 38 | 49 | 38 | 32 | 38 | 39 | 33 | |
| Days Payable | 288 | 150 | 102 | 57 | 64 | 240 | 270 | 173 | 228 | 200 | 198 | |
| Cash Conversion Cycle | 742 | -75 | -22 | -13 | 6 | -4 | -170 | -210 | -122 | -163 | -139 | -143 |
| Working Capital Days | -11,217 | -74 | -67 | -17 | -28 | 21 | -94 | -72 | -55 | -29 | -33 | -15 |
| ROCE % | 12% | -5% | -4% | -4% | -1% | 2% | 3% | -1% | 4% | 7% | 7% | 139% |
Documents
Announcements
-
Monthly Report On Special Window For Re-Lodgement Of Shares
8 Dec - No special-window re-lodgement requests received or processed in November 2025 for Aster DM Healthcare.
-
Monthly Report On Special Window For Re-Lodgement Of Shares
8 Dec - October 2025 re-lodgement report: zero share transfer requests processed, approved, or rejected.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
3 Dec - Aster DM to attend Elara Capital Bengaluru Corporate Day 2025 investor meetings on 08-Dec-2025 (physical).
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
23 Nov - Company to participate in virtual JP Morgan investor meetings on Nov 26–27, 2025 (India Emerging Opportunities Fund).
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
23 Nov - Aster DM Healthcare to attend JP Morgan investor meetings on 26-27 Nov 2025, virtual one-on-one and investor group.
Annual reports
Concalls
-
Nov 2025Transcript PPT
-
Nov 2025TranscriptAI SummaryPPT
-
Aug 2025Transcript PPT
-
May 2025Transcript PPT
-
Feb 2025Transcript PPT
-
Dec 2024Transcript PPT
-
Nov 2024TranscriptAI SummaryPPT
-
Nov 2024Transcript PPT
-
Oct 2024TranscriptAI SummaryPPT
-
Aug 2024Transcript PPT
-
Jun 2024Transcript PPT
-
May 2024TranscriptAI SummaryPPT
-
Feb 2024Transcript PPT
-
Feb 2024TranscriptAI SummaryPPT
-
Dec 2023Transcript PPT
-
Nov 2023TranscriptAI SummaryPPT
-
Nov 2023TranscriptAI SummaryPPT
-
Aug 2023Transcript PPT
-
Jun 2023Transcript PPT REC
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Aug 2022TranscriptPPT
-
Aug 2022Transcript PPT
-
May 2022Transcript PPT
-
Feb 2022Transcript PPT
-
Nov 2021Transcript PPT
-
Sep 2021TranscriptPPT
-
Aug 2021Transcript PPT
-
Jun 2021Transcript PPT
-
Mar 2021TranscriptPPT
-
Feb 2021Transcript PPT
-
Dec 2020TranscriptPPT
-
Nov 2020Transcript PPT
-
Aug 2020Transcript PPT
-
Jun 2020Transcript PPT
-
Jun 2020TranscriptAI SummaryPPT
-
Feb 2020Transcript PPT
-
Feb 2020TranscriptAI SummaryPPT
-
Nov 2019Transcript PPT
-
Sep 2019Transcript PPT
-
Aug 2019Transcript PPT
-
Jun 2019Transcript PPT
-
May 2019TranscriptPPT
-
Mar 2019TranscriptPPT
-
Feb 2019Transcript PPT
-
Nov 2018TranscriptAI SummaryPPT
-
Sep 2018TranscriptPPT
-
Aug 2018Transcript PPT
-
Jun 2018Transcript PPT
Merger of Aster DM & Quality Care[1]
Aster DM and Blackstone-backed Quality Care are to merge and create one of the top 3 hospital chains in India with 10,360+ beds. The merged listed entity will be named Aster DM Quality Care Limited and will be one of the largest M&A in the hospital space in India based on number of operational beds. Aster acquired a 5.0% stake in QCIL from Blackstone and TPG in consideration of primary share issuance by Aster for 3.6% stake followed by merger of QCIL into Aster by way of a scheme of amalgamation.
Inter-se shareholding between Aster DM and Quality Care shareholders would be 57.3% and 42.7% respectively. The merger is cash neutral and is expected to be EPS accretive from 1st full year of operations.